The Sexually Transmitted Disease (STD) Testing Market is being driven by Increasing prevalence of STDs
The Sexually Transmitted Disease (STD) Testing Market is expected to grow at a CAGR of 5.6% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 32.37 billion. The Sexually Transmitted Disease (STD) testing market is experiencing a notable transition from conventional laboratory testing to rapid point-of-care (POC) testing. POC HIV testing, in particular, has gained widespread acceptance due to its ability to surmount patient and provider barriers to routine screening. The preference for self-testing for HIV is increasingly popular in developed nations. Home HIV test kits or self-testing in a domestic setting detect the presence of HIV-1/2 antibodies or HIV-1 p24 antigen. The effectiveness of POC testing is amplified by the emergence of sensors, microsystems, and affordable imaging technologies. Furthermore, the STD testing market is witnessing swift advancements in molecular diagnostics, which are increasingly being utilized for STD testing.
Get more information on Sexually Transmitted Disease (STD) Testing Market by requesting a sample report
The market is segmented based on segments_for_ai.nslist
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
176 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.6% |
Market growth 2024-2028 |
USD 32.37 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
5.22 |
Key countries |
US, Germany, UK, Canada, and China |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Sexually Transmitted Diseases (STD) diagnostics market encompasses the detection of various Infectious Diseases, including HIV, Gonorrhea, Syphilis, Hepatitis C virus, Human immunodeficiency virus (HIV), Human papillomavirus (HPV), Malaria, Tuberculosis, and AIDS. This market caters to the needs of Health Organizations, Hospitals and clinics, Diagnostic centers, and home-based tests. Technological advancements have led to the development of Point-of-Care (POC) testing, which allows for early disease detection at decentralized locations, as opposed to centralized laboratories. Some common STDs include HIV, Gonorrhea, Syphilis, Hepatitis C virus, Human papillomavirus (HPV), and AIDS statistics. Other diseases like Malaria and Tuberculosis are also diagnosed through this market.
The global life sciences tools and services market encompasses organizations involved in the research and development (R&D) of various product categories, including capital equipment, instruments, accessories, and consumables for pharmaceuticals and biotechnology, as well as laboratory diagnosis of infectious diseases such as HIV, Gonorrhea, and Syphilis. According to Technavio, this market's growth is attributable to several factors, including the increasing global population aging, resulting in a larger demographic susceptible to infectious diseases. Additionally, the advancement of point-of-care testing technology is expected to significantly impact the market, enabling faster and more accurate diagnosis of HIV, AIDS, and other infectious diseases. The global healthcare market size is calculated based on the combined revenue generated by manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and life science tools and services.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted